News

OmniComm Systems has announced that it has been selected by a leading European Contract Research Organization (CRO), to provide eClinical solutions for a pivotal phase III study in

Verizon introduces two new capabilities designed to help safeguard the growing exchange of electronic patient data between hospitals, clinics, physicians, insurers and patients. The company claims that the

The Brain Tumor Research Center at the University of California, San Francisco, has begun enrolling patients into a phase 2 clinical trial of Oncophage (vitespen), in combination with

Accera has announced that data showed that using ketone bodies can be an effective and safe method to approach Alzheimer’s Disease. The results were published as scientific paper

Dynavax has met with the European Medicines Evaluation Agency (EMEA) to discuss its plans for continued clinical development of HEPLISAV phase 3 investigational adult hepatitis B vaccine in

Clinical Data has entered into a collaboration and licensing agreement with CombinatoRx to develop an adenosine A2A agonist compound in a combination therapy. It is intended for the

The US Food and Drug Administration has accepted to file Theratechnologies’ New Drug Application (NDA) for its lead compound, tesamorelin. Under the terms of the company’s collaboration and

Cannabis Science has completed its review of the FDA licensing requirements and has made key progress with mapping out its initial cannabis drug medicines for FDA clinical trials.

Astellas has received the notice that FDA has substantially denied the company’s Citizen Petition, which had been submitted on September 2007, to ensure the safe and effective use